Over 30% Covaxin takers suffered from health issues after one year: BHU study

The study found that adverse events of special interest or AESI were reported in 50 per cent of the participants who took #Covaxin vaccine
https://thesouthfirst.com/health/over-30-covaxin-takers-suffered-from-health-issues-after-one-year-bhu-study/

Over 30% Covaxin takers suffered from health issues after one year: BHU study

The study found that adverse events of special interest or AESI were reported in 50 per cent of the participants who took Covaxin vaccine

The SouthFirst

"Bharat Biotech reported promising data on the nasal #Covid #vaccine this week. The #NasalVaccine against Covid was safe, well tolerated & elicited superior antibody levels & mucosal immune responses compared with 2 doses of the intramuscular #Covaxin vaccine. Hopefully this nasal vaccine will be approved in the United States soon as it helps block the Covid virus from entering the body." 3/n

https://drruth.substack.com/p/covid-news-2423

COVID news 2/4/23

Hi all, XBB.1.5 increased from 61% last week to 66% of U.S. cases this week, but overall hospitalizations and wastewater virus levels are falling despite XBB.1.5 being much more contagious and immune evasive. This is very good news. But, we still have to remember that there are more than 400 people dying each day of Covid across the United States and we cannot let our guard down.

Dr. Ruth’s Newsletter
I'm really hoping the Indian government is collecting good surveillance data around the intranasal #Covaxin vaccine, and will be able to compute an effectiveness estimate against actual transmission soon. It's the world's first mass-deployed mucosal COVID vaccine. Pay attention.

After carefully evaluating the risks associated with all #COVID19 #vaccines available in #India, & after getting the expert opinion of specialists, I got double #vaccinated with #BharatBiotech's #Covaxin in '21. My family & 2 of my friends did the same.

Except for 1 friend, the rest of us all eventually got a mild form of #COVID in '22, which we recovered from (2 ~ 5 days). So, I was planning to avoid the booster dose.

Now, I don't mind getting the #nasalvaccine, because it is VERY SAFE! 👍 👌 👏

Bravo #BharatBiotech! 👏👏

The ONLY way to deal with #COVID #vaccine hesitancy among citizens is by making vaccines SAFER & by being VERY TRANSPARENT about their #sideeffects, and NOT by the outrageous #vaccinemandates!

Bharat Biotech's #Covaxin is among the safest #COVID19 #vaccines. It is a whole-virion inactivated vaccine, & has reported very few adverse events.

Now, Bharat Biotech has released AN EVEN SAFER #nasalvaccine, the non-injected nasal version of Covaxin! 👏

https://www.indiatoday.in/coronavirus-outbreak/story/bharat-biotech-nasal-covid-vaccine-out-as-booster-dose-2312377-2022-12-22

Bharat Biotech’s nasal Covid vaccine to be rolled out as booster dose | Exclusive

Bharat Biotech’s nasal Covid vaccine to be rolled out as booster dose

India Today

https://www.statnews.com/pharmalot/2022/11/15/vaccine-covid19-india-bharat-covaxin-transparency-protocols/

Serious lapses has been exposed in the making of #COVAXIN and the way Govt diluted mandatory protocols for PR.

This should be seen with the way many died in an African nation due to our drug.

RG raised this, they accused us of Vaccine hesitancy.

'A very worrying scenario': Internal documents on India Covid-19 vaccine raise troubling questions about approval process

A STAT review of documents on Bharat Biotech's Covid-19 vaccine found that regulators endorsed the vaccine despite discrepancies in the number of enrollees.

STAT
A #Lista sem fim de #Sigilos de #100Anos impostos por B0Is0nar0 ( #PL RJ) -
jornalistaslivres.org/a-lista-… -
RT @J_LIVRES - Via Jornalistas Livres -
#CartãoDeVacinação, Processo contra #Pazuello, #Visitas ao Palácio do Planalto, #Rachadinhas, Caso #Genivaldo, Documentos da #Vacina #Covaxin -
A lista sem fim de sigilos de 100 anos impostos por Bolsonaro

Covaxin, rachadinha, Pazuello... confira a lista de sigilos de 100 anos impostos durante o governo de Jair Bolsonaro

Jornalistas Livres
Exclusive: Covaxin’s Manufacturing Practices Remain ‘Unacceptable’ Says WHO – The Wire Science

6-12 வயதினருக்கு இன்று முதல் கொரோனா தடுப்பூசி
https://patrikai.com/the-first-corona-vaccine-for-6-12-year-olds-today/ via @[email protected]

#COVID19 #COVID #vaccination #VaccinationForKids #COVAXIN

6-12 வயதினருக்கு இன்று முதல் கொரோனா தடுப்பூசி

புதுடெல்லி: 6- 12 வயது வரையிலான சிறுவர்களுக்கு இன்று முதல் கோவாக்சின் கொரோனா தடுப்பூசி போடப்படும் என பிரதமர் மோடி கூறியுள்ளார். நாடு கொரோனா வைரஸ் தொற்றின் மூன்றாவது அலையை முடிவுக்கு கொண்டு வர தொடர்ந்து முழுவீச்சுடன் போராடி வருகிறது. தேசிய அளவில் கொரோனா தொற்று பாதிப்பு குறைந்து கட்டுக்குள் இருந்து வந்தது. ஆனால் கடந்த சில நாட்களாக இதில் மாற்றம் ஏற்பட்டது. தினசரி தொற்று பாதிப்பு மெல்ல, மெல்ல எழுச்சி பெறத்தொடங்கியது. குறிப்பாக டெல்லி, அரியானா,...

www.patrikai.com

#Breaking கோவாக்சின் தடுப்பூசியை 6-12 வயது சிறார்களுக்கு செலுத்த அனுமதி - இந்திய மருந்து கட்டுப்பாட்டு ஆணையம் ஒப்புதல்!!

#COVAXIN #Vaccine #India http://patrikai.com

Homepage

Homepage

www.patrikai.com